NCT04134260 2026-01-14Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE TrialNRG OncologyPhase 3 Recruiting586 enrolled